Discover Marpai, Inc.'s Q2 2025 earnings insights, highlighting the transformative relaunch of MarpaiRx, cost reductions, and a roadmap to profitability ...

A federal judge on Monday halted proceedings in the challenge against Arkansas’ first-in-the-nation regulations on pharmacy ...

The American Medical Association’s research, which found that local PBM markets are highly concentrated, is more fuel for ...

Over the past two years, our area has experienced "mass closures" of several pharmacy chains and independent stores, ...

The state's new law has implications for employer plans, benefits advisors and patients all around the country ...

Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% ...

The PBM exam guidelines project: The NAIC already has a Market Regulation Handbook that helps states assess insurers and ...

A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

One week from now, national pharmacy benefit manager Express Scripts is expected to terminate its coverage with locally-owned ...

Starting in January, Navitus Health Solutions members will see cost-plus pricing at Costco Pharmacy for select prescriptions.

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...